Carrie Fitzpatrick to Myelodysplastic Syndromes
This is a "connection" page, showing publications Carrie Fitzpatrick has written about Myelodysplastic Syndromes.
Connection Strength
0.275
-
Karyotypic clonal fraction predicts adverse outcome in TP53-mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study. J Clin Pathol. 2025 Aug 18; 78(9):629-635.
Score: 0.178
-
Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 2017 05; 31(5):1226-1229.
Score: 0.098